Well it looks like we enjoyed the run while it lasted, and could be headed for that painful drip. I know this news was not as significant as some of the others recently, but a slight uptick in volume with a drop in price, was our norm for years on any news.
Unless we get some news with some teeth, I dread where this may go. I just don't see us getting anything like that in the near term. Otherwise why do that raise? They clearly stated enough until 1Q19. Yes with contingency plan to do it, but the ATM would have mitigated that you would think.
I sincerely doubt any government contract either stockpiling or trial funding is in the works. Or again, why now with the raise. To use the funds for increasing manufacturing capacity in any significant way, would not make sense to me at all. Any order we could possibly receive (which I doubt) could be handled easily with existing facilities. Then you still have at least 6 months to a year for pivotal trial to be complete.
That whole Lonza thing is even more ludicrous imo. If we have the technology Lonza wants, I wouldn't think we would need cash in any way. They would be forking out the dough for any such thing, making the raise pointless.
I think this raise was done mainly to have enough cash on hand to get this Sosei deal done before the end of the year. They need to get this PMDA fast track living up to its name. Not sure if any data from the ongoing CLI could be used in the Japanese trial. I doubt it but I hope so.
So that is what I think what we will get very soon. Sosei. Not sure if that will have any impact on our price, but we will see.
As always, IMO, and I hope I'm wrong and we get some contract news with some real cash. Something to make US happy by the end of the year. But one thing for sure. Get this pivitol ARS trial on the go ASAP!!!
